T 1087/19 (Treatment of PNH by inhibitor of complement / ALEXION PHARMACEUTICALS) of 20.09.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T108719.20230920
- Date of decision
- 20 September 2023
- Case number
- T 1087/19
- Petition for review of
- -
- Application number
- 11001632.6
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement
- Applicant name
- Alexion Pharmaceuticals, Inc.
- Opponent name
- O1: Amgen Inc.
O2: Hoffmann Eitle - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(b)European Patent Convention Art 112aEuropean Patent Convention R 106
- Keywords
- Sufficiency of disclosure (no)
Obligation to raise objections - objection dismissed - Catchword
- -
- Cited cases
- T 0890/02
- Citing cases
- -
Order
For these reasons it is decided that:
1. The objection under Rule 106 EPC is dismissed.
2. The appeal is dismissed.